Description
GLOW 70 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product. Not a cosmetic.
Research-grade synthetic peptide blend supplied as a 70 mg total sealed vial for lawful laboratory research in the UK. Not a food, supplement, serum or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | GLOW |
| Type | Catalogue research blend |
| Supplier | Opti-Gen Peptides |
| Contents | 70 mg total per vial |
| Common catalogue components (confirm COA) | Often GHK-Cu (CAS 89030-95-5) + BPC-157 (CAS 137525-51-0) + TB-500 / thymosin β4–related peptide |
| Intended use | Laboratory / in-vitro research only |
The word GLOW Peptide Blend is a brand/catalogue label only. It is not a claim about skin appearance.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No topical, reconstitution or injection instructions on this page.
Published research context (not product claims)
If the COA lists GHK-Cu, published work is the Pickart copper-tripeptide cell and gene-expression literature. Cosmetic INCI use of copper tripeptide-1 is separate and is not a claim for this blend.
If the COA lists BPC-157, papers are the Sikiric gastric-peptide assay series. FDA compounding communications have flagged BPC-157.
If the COA lists TB-500 / thymosin β4, papers concern G-actin / cell-motility models. Full-length Tβ4 and short fragments are not interchangeable without the COA.
Combining those papers into a “skin glow stack” is not permitted product copy. BPC-157 and thymosin β4 appear in WADA discussions. There is no UK marketing authorisation.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.